Mounjaro refills: how early can you get one?
Dr. Linda's take
Mounjaro and Zepbound are both built on tirzepatide, but they are two separate FDA-approved products, approved for different uses, with their own individually issued prescribing information. Patients on Mounjaro often ask about refill timing assuming it works exactly like Zepbound, and while the labels turn out to say very similar things, treating them as identical is a guess, not a fact, until you check Mounjaro's own label. This piece focuses specifically on what Mounjaro's FDA label says about its weekly schedule and a missed dose. For the general framework behind why a drug's dosing schedule and a pharmacy's refill window are two separate questions, see how soon can you refill your GLP-1 medication?
What is Mounjaro's weekly dosing schedule?
According to Mounjaro's current FDA prescribing information, the recommended starting dosage is 2.5 mg injected subcutaneously once weekly. After 4 weeks, the label instructs increasing the dosage to 5 mg injected subcutaneously once weekly. If additional glycemic control is needed, the label allows the dosage to be increased further in 2.5 mg increments, after at least 4 weeks on the current dose. The maximum labeled dosage is 15 mg injected subcutaneously once weekly for adults, and a lower maximum of 10 mg injected subcutaneously once weekly applies to pediatric patients 10 years of age and older.
What does the Mounjaro label say about a missed dose?
Mounjaro's label states that if a dose is missed, it should be administered as soon as possible within 4 days, or 96 hours, of the missed dose. If more than 4 days have passed, the label instructs skipping that dose and administering the next dose on the regularly scheduled day, then resuming the normal weekly schedule. The label also permits changing the day of weekly administration if needed, as long as at least 3 days, or 72 hours, separate the two doses.
Why might your Mounjaro refill come early or late?
Several practical factors can shift when a Mounjaro refill actually shows up, separate from the drug's own schedule. Early in treatment, each step up through the label's 2.5 mg dose increments, from the 2.5 mg starting dose toward the 15 mg adult maximum, typically represents its own prescription strength, and a dose change can reset a supply countdown even without any change to the weekly injection habit. Pharmacy processing, prior-authorization renewals, and mail-order shipping timelines can also move the date medication actually arrives, independent of the label's schedule. On the insurance side, refill-too-soon windows are set by the plan and pharmacy, not by Mounjaro's label, and they vary from one plan to the next, so there is no single day-count that applies universally.
Does Mounjaro's titration schedule affect refill timing?
It can, especially in the first several months of treatment. Because Mounjaro's dosage is typically adjusted every 4 weeks while a patient and clinician work toward an effective dose for glycemic control, a new prescription strength and a refill often land close together during that titration period. Once a stable maintenance dose is reached, refill timing tends to follow a steadier weekly pattern.
Is Mounjaro's missed-dose window the same as Zepbound's?
The current labels for both use closely matching language on this specific point: both allow a missed dose within 4 days, or 96 hours, and both instruct skipping the dose and resuming the regular schedule beyond that window. That similarity makes sense since both medications share the same active ingredient, tirzepatide, but Mounjaro and Zepbound remain separate FDA-approved products with separately issued labels, and their approved uses, titration details, and pediatric dosing differ. For the Zepbound-specific breakdown, see how fast can you refill Zepbound?
Frequently asked questions
How many days after a missed Mounjaro dose can it still be taken?
Mounjaro's FDA label instructs administering a missed dose as soon as possible within 4 days, or 96 hours, of the missed dose. Beyond that window, the label instructs skipping the missed dose and resuming the regular weekly schedule at the next planned dose.
Can the weekly Mounjaro injection day be changed?
The label allows the day of weekly administration to be changed if needed, as long as at least 3 days, or 72 hours, separate the two doses. Any change to an injection routine is worth discussing with a prescribing clinician.
Why does my Mounjaro refill date shift while I'm still increasing doses?
Because each new strength during the titration period ships as its own prescription, a dose change can shift the refill date on its own, separate from the weekly injection habit itself. This tends to settle once a stable maintenance dose is reached.
Does insurance decide how early I can pick up a Mounjaro refill?
For the pharmacy side of the question, largely yes. Refill-too-soon rules come from the insurance plan and pharmacy, not from Mounjaro's FDA label, and they vary by plan.
Is Mounjaro dosed the same way as Zepbound?
Both are tirzepatide and share very similar missed-dose language, but they are separate FDA-approved products with their own labels and their own approved uses. See how fast can you refill Zepbound? for the Zepbound-specific details.
References
1. U.S. Food and Drug Administration / Eli Lilly and Company (2026). MOUNJARO (tirzepatide) injection, for subcutaneous use, prescribing information (Revised 4/2026), DailyMed. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0 (Accessed 2026-07-12).
2. U.S. Food and Drug Administration / Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection, for subcutaneous use, prescribing information (Revised 4/2026), DailyMed. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (Accessed 2026-07-12).
Keep reading
Can a GLP-1 help with weight gain after menopause?
A sourced guide to how GLP-1 medications work for weight gain after menopause, including the muscle-preservation and safety caveats.
Can you use a GLP-1 and hormone therapy together in perimenopause?
A sourced look at whether a GLP-1 and menopausal hormone therapy can be used together in perimenopause, and what to ask your clinician.
Are Black and Latina women at higher risk for obesity and type 2 diabetes?
A sourced look at what US prevalence data show about obesity and type 2 diabetes risk among Black and Latina women, and why it matters.
What are the side effects of a GLP-1 when you have PCOS?
A clear, sourced guide to the side effects of GLP-1 medications when you have PCOS, and what to ask your clinician.
Can a GLP-1 reverse prediabetes?
"Reverse" is the wrong mental model. These medications hold progression to type 2 diabetes back while you take them, but the STEP 1 extension shows normal glucose levels largely drift back after stopping.
Do GLP-1 medications work as well for Black and Latina women?
Where efficacy has been analyzed by race and ethnicity, these medications worked, with no significant difference in treatment effect. The documented inequity is not in the pharmacology. It is in who gets offered treatment.
